These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 16926619)
41. Examining the criterion-related validity of the Pervasive Developmental Disorder Behavior Inventory. McMorris CA; Perry A Autism; 2015 Apr; 19(3):272-80. PubMed ID: 24463433 [TBL] [Abstract][Full Text] [Related]
42. Open trial of risperidone in 24 young children with pervasive developmental disorders. Masi G; Cosenza A; Mucci M; Brovedani P J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534 [TBL] [Abstract][Full Text] [Related]
43. [Factor structure and reliability of the Spanish adaptation of the Children's Yale-Brown Obsessive-Compulsive Scale--Self Report (CY-BOCS-SR)]. Godoy A; Gavino A; Valderrama L; Quintero C; Cobos MP; Casado Y; Sosa MD; Capafons JI Psicothema; 2011 Apr; 23(2):330-5. PubMed ID: 21504689 [TBL] [Abstract][Full Text] [Related]
44. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. King BH; Dukes K; Donnelly CL; Sikich L; McCracken JT; Scahill L; Hollander E; Bregman JD; Anagnostou E; Robinson F; Sullivan L; Hirtz D JAMA Pediatr; 2013 Nov; 167(11):1045-52. PubMed ID: 24061784 [TBL] [Abstract][Full Text] [Related]
45. Risperidone: a potential treatment for autism. Posey DJ; McDougle CJ Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417 [TBL] [Abstract][Full Text] [Related]
46. [Similarities and differences between the behavior of Asperger's syndrome and obsessive-compulsive disorder]. Hashimoto O Nihon Rinsho; 2007 Mar; 65(3):506-11. PubMed ID: 17354567 [TBL] [Abstract][Full Text] [Related]
47. Validation of the yale-brown obsessive compulsive scale modified for binge eating. Deal LS; Wirth RJ; Gasior M; Herman BK; McElroy SL Int J Eat Disord; 2015 Nov; 48(7):994-1004. PubMed ID: 26032442 [TBL] [Abstract][Full Text] [Related]
48. A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. Stigler KA; Desmond LA; Posey DJ; Wiegand RE; McDougle CJ J Child Adolesc Psychopharmacol; 2004; 14(1):49-56. PubMed ID: 15142391 [TBL] [Abstract][Full Text] [Related]
49. Validity and reliability of the Brazilian version of Yale-Brown obsessive compulsive scale-shopping version (YBOCS-SV). Leite PL; Filomensky TZ; Black DW; Silva AC Compr Psychiatry; 2014 Aug; 55(6):1462-6. PubMed ID: 24894733 [TBL] [Abstract][Full Text] [Related]
50. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308 [TBL] [Abstract][Full Text] [Related]
51. [Validity and reliability of the Spanish version of Yale-Brown obsessive-compulsive rating scale for children and adolescents]. Ulloa RE; de la Peña F; Higuera F; Palacios L; Nicolini H; Avila JM Actas Esp Psiquiatr; 2004; 32(4):216-21. PubMed ID: 15232750 [TBL] [Abstract][Full Text] [Related]
52. Reliability and accuracy of differentiating pervasive developmental disorder subtypes. Mahoney WJ; Szatmari P; MacLean JE; Bryson SE; Bartolucci G; Walter SD; Jones MB; Zwaigenbaum L J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):278-85. PubMed ID: 9519632 [TBL] [Abstract][Full Text] [Related]
53. Cognitive profile difference between normally intelligent children with Asperger's disorder and those with pervasive developmental disorder not otherwise specified. Koyama T; Kurita H Psychiatry Clin Neurosci; 2008 Dec; 62(6):691-6. PubMed ID: 19068006 [TBL] [Abstract][Full Text] [Related]
54. [Validation of a version in Spanish of the Yale-Brown Obsessive-Compulsive Scale]. Vega-Dienstmaier JM; Sal Y Rosas HJ; Mazzotti Suárez G; Vidal H; Guimas B; Adrianzén C; Vivar R Actas Esp Psiquiatr; 2002; 30(1):30-5. PubMed ID: 11893289 [TBL] [Abstract][Full Text] [Related]
55. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. McDougle CJ; Kresch LE; Goodman WK; Naylor ST; Volkmar FR; Cohen DJ; Price LH Am J Psychiatry; 1995 May; 152(5):772-7. PubMed ID: 7726318 [TBL] [Abstract][Full Text] [Related]
56. A prospective open trial of guanfacine in children with pervasive developmental disorders. Scahill L; Aman MG; McDougle CJ; McCracken JT; Tierney E; Dziura J; Arnold LE; Posey D; Young C; Shah B; Ghuman J; Ritz L; Vitiello B J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547 [TBL] [Abstract][Full Text] [Related]
57. Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study. Miyaoka T; Wake R; Furuya M; Liaury K; Ieda M; Kawakami K; Tsuchie K; Inagaki T; Horiguchi J BMC Psychiatry; 2012 Nov; 12():215. PubMed ID: 23194148 [TBL] [Abstract][Full Text] [Related]
58. The Brown Assessment of Beliefs Scale: reliability and validity. Eisen JL; Phillips KA; Baer L; Beer DA; Atala KD; Rasmussen SA Am J Psychiatry; 1998 Jan; 155(1):102-8. PubMed ID: 9433346 [TBL] [Abstract][Full Text] [Related]
59. Role of risperidone in children with autism spectrum disorder. Chavez B; Chavez-Brown M; Rey JA Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811 [TBL] [Abstract][Full Text] [Related]
60. Development and validation of the outburst monitoring scale for children and adolescents. Kronenberger WG; Giauque AL; Dunn DW J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):511-26. PubMed ID: 17822345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]